Yahoo Finance

Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

SAN DIEGO, CA, and ANAHEIM, CA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated ...
Nasdaq

Recro Completes Separation of Baudax Bio and Becomes a Dedicated Contract Development and Manufacturing Organization

MALVERN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a high-performing, revenue generating contract development and manufacturing organization (CDMO), today announced that ...
Yahoo Finance

Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
Nasdaq

Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
FiercePharma

Recro Pharma takes manufacturing business 'bi-coastal' with $50M deal for CDMO Irisys

With manufacturing operations already locked up in Georgia, Recro Pharma is taking its CDMO ambitions coast-to-coast. Recro has dished out nearly $50 million to acquire CDMO peer Irisys. The deal for ...
Business Insider

Recro Announces Pricing of $30.0 Million Public Offering of Common Stock

EXTON, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
Business Wire

Recro Gainesville Hires Industry Veteran to Lead Business Development Team

GAINESVILLE, Ga.--(BUSINESS WIRE)--Recro Gainesville, LLC, a wholly owned subsidiary of Recro Pharma, Inc., and a leading provider of solid oral dose manufacturing services for the pharmaceutical ...
Business Wire

Kaskela Law LLC Files Shareholder Class Action Lawsuit Against Recro Pharma, Inc.

RADNOR, Pa.--(BUSINESS WIRE)--Kaskela Law LLC has filed a shareholder class action lawsuit against Recro Pharma, Inc. (NASDAQ: REPH) (“Recro” or the “Company”) on behalf of investors who purchased or ...
Business Insider

Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with ...
Benzinga.com

Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego

SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...
Benzinga.com

Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...